4.1. Study Design and Participants
Participants involved in the present investigation were adults with long COVID who were enrolled in a placebo-controlled randomized clinical trial that tested the effects of a combination of Trial participants and healthy controls were asked to refrain from exercising and consuming any product with vasoactive properties (e.g., tobacco, caffeinated drinks) for at least 12 h before blood drawing.